Raymond Joseph Tesi - Mar 21, 2022 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Raymond Joseph Tesi
Stock symbol: INMB
Transactions as of: Mar 21, 2022
Transactions value $: $199,993
Form type: 4
Date filed: 3/23/2022, 04:33 PM
Previous filing: Nov 4, 2021
Next filing: May 31, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INMB	Common Stock	Award	$200K	+23.7K	+1.59%	$8.43	1.51M	Mar 22, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INMB	Option (right to buy)	Award	$0	+130K		$0.00	130K	Mar 21, 2022	Common Stock	130K	$7.92	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities . These shares were purchased by the Reporting Person directly from Issuer.
F2	Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.